Pricing Log in Create free account

Ernexa Therapeutics Inc. (ERNA) vs Propanc Biopharma Inc (PPCB)

Ernexa Therapeutics Inc. and Propanc Biopharma Inc are both Biotechnology companies. Ernexa Therapeutics Inc. and Propanc Biopharma Inc are of similar size ($3.5M and $3.5M). Across the 10 metrics below, Ernexa Therapeutics Inc. leads on 5 and Propanc Biopharma Inc on 5.

Valuation

Metric ERNA PPCB Biotechnology median
P/E n/m n/m 8.50
P/S 4.25 n/m 9.71
P/B 0.77 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 51.19 n/m 9.21
Earnings yield (686.60%) (5,398.12%) (33.15%)
Free cash flow yield (359.07%) (1,488.65%) (25.50%)

Profitability

Metric ERNA PPCB Biotechnology median
Gross margin 83.51% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (169.85%) (56.36%)
Return on assets (176.62%) (122.15%) (48.04%)
Return on invested capital 0.00% (125.86%) 0.00%

Growth

Metric ERNA PPCB Biotechnology median
Revenue growth (TTM) (78.60%) — 6.02%
EPS growth (last fiscal year) 95.42% 95.25% 30.26%
Revenue growth, 5-year CAGR (52.20%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 2.01 2.55 4.72
Net debt to EBITDA 0.21 0.02 0.96

Dividend

Metric ERNA PPCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ERNA PPCB Biotechnology median
Market cap 3.54m 3.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack